These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 29650896)

  • 1. [The Combination of Molecular Targeted Agents with Radiotherapy in Head and Neck Cancer].
    Furuta M; Yokota T
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):419-423. PubMed ID: 29650896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
    Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients.
    Kurokawa M; Watanabe Nemoto M; Harada R; Kobayashi H; Horikoshi T; Kanazawa A; Togasaki G; Abe Y; Chazono H; Hanazawa T; Okamoto Y; Uno T
    J Radiat Res; 2015 Sep; 56(5):849-55. PubMed ID: 26160181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficiency and adverse events of radiotherapy with cetuximab for Japanese head and neck cancer patients.
    Hirasawa K; Okamoto I; Motohashi R; Sato H; Takase S; Agata A; Takeda A; Tsukahara K
    Auris Nasus Larynx; 2017 Dec; 44(6):724-728. PubMed ID: 28237712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
    Ou D; Levy A; Blanchard P; Nguyen F; Garberis I; Casiraghi O; Scoazec JY; Janot F; Temam S; Deutsch E; Tao Y
    Oral Oncol; 2016 Aug; 59():50-57. PubMed ID: 27424182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis.
    Huang J; Zhang J; Shi C; Liu L; Wei Y
    BMC Cancer; 2016 Aug; 16(1):689. PubMed ID: 27565887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2).
    Ota Y; Kodaira T; Fujii H; Shimokawa M; Yokota T; Nakashima T; Monden N; Homma A; Ueda S; Akimoto T
    Int J Clin Oncol; 2022 Nov; 27(11):1675-1683. PubMed ID: 36001247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
    Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
    Bourhis J; Lefebvre JL; Vermorken JB
    Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complication and surgical site infection for salvage surgery in head and neck cancer after chemoradiotherapy and bioradiotherapy.
    Suzuki H; Hanai N; Nishikawa D; Fukuda Y; Hasegawa Y
    Auris Nasus Larynx; 2017 Oct; 44(5):596-601. PubMed ID: 28043710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.
    Kawai S; Yokota T; Onozawa Y; Hamauchi S; Fukutomi A; Ogawa H; Onoe T; Onitsuka T; Yurikusa T; Todaka A; Tsushima T; Yoshida Y; Kito Y; Mori K; Yasui H
    BMC Cancer; 2017 Jan; 17(1):59. PubMed ID: 28095814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Griffin S; Walker S; Sculpher M; White S; Erhorn S; Brent S; Dyker A; Ferrie L; Gilfillan C; Horsley W; Macfarlane K; Thomas S
    Health Technol Assess; 2009 Jun; 13 Suppl 1():49-54. PubMed ID: 19567214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer.
    Shirasu H; Yokota T; Hamauchi S; Onozawa Y; Ogawa H; Onoe T; Onitsuka T; Yurikusa T; Mori K; Yasui H
    BMC Cancer; 2020 Mar; 20(1):182. PubMed ID: 32131771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
    Nishimura G; Taguchi T; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki K; Arai Y; Takahashi H; Hata M; Oridate N
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1315-9. PubMed ID: 27154176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
    Buglione M; Maddalo M; Corvò R; Pirtoli L; Paiar F; Lastrucci L; Stefanacci M; Belgioia L; Crociani M; Vecchio S; Bonomo P; Bertocci S; Borghetti P; Pasinetti N; Triggiani L; Costa L; Tonoli S; Grisanti S; Magrini SM
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):462-472. PubMed ID: 27986347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
    Mody MD; Gill HS; Saba NF
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.
    Swiecicki PL; Li P; Bellile E; Stucken C; Malloy K; Shuman A; Spector ME; Chinn S; Casper K; McLean S; Moyer J; Chepeha D; Wolf GT; Prince M; Bradford C; Nyati M; Eisbruch A; Worden FP; Jolly S; Mierzwa M
    Head Neck; 2020 Aug; 42(8):1728-1737. PubMed ID: 31989702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?
    Bernier J; Schneider D
    Eur J Cancer; 2007 Jan; 43(1):35-45. PubMed ID: 17098420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of concurrent cisplatin versus cetuximab with radiotherapy in locally-advanced head and neck cancer: A bi-institutional analysis.
    Stokes WA; Sumner WA; Breggren KL; Rathbun JT; Raben D; McDermott JD; Gan G; Karam SD
    Rep Pract Oncol Radiother; 2017; 22(5):389-395. PubMed ID: 28808428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial.
    Ghosh-Laskar S; Kalyani N; Gupta T; Budrukkar A; Murthy V; Sengar M; Chaukar D; Pai P; Chaturvedi P; D'Cruz A; Agarwal J
    Head Neck; 2016 Feb; 38(2):202-7. PubMed ID: 25224814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.